PTGX Competitors & Alternatives
Compare Protagonist Therapeutics Inc with similar stocks in the same industry
Biotechnology
PTGX
Main Stock$129.89
Tradestie Score
67
Market Cap
$3.98B
Revenue Growth
1.0%
Analyst Upside
-7.2%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$83.08
|
$10.22B | - | 67 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$531.00
|
$10.01B | - | 66 | Compare |
|
TECH
Bio-Techne Corp.
|
$71.36
|
$9.33B | 101.9 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$85.90
|
$8.88B | 262.5 | 60 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$76.11
|
$8.77B | 26.7 | 58 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$183.95
|
$8.57B | - | 57 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$17.06
|
$8.53B | - | 55 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$236.97
|
$8.30B | 2031.8 | 67 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$82.24
|
$6.68B | - | 60 | Compare |
More PTGX Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry